by
deng yue Wed at 1:17 AM
As precision oncology continues to evolve, HER2 (human epidermal growth factor receptor 2) has become one of the most established and clinically valuable therapeutic targets across a broad spectrum of solid tumors. With increasing insight into tumor heterogeneity and mechanisms of treatment resistan...
